Exploring the effects of doxorubicin on survival rates in glioma patients: a comprehensive systematic review

Abstract Background Glioma is still one of the most aggressive and common types of brain and central nervous system cancer, with few effective treatment options. Despite progress in therapy, there is a requirement for new methods to enhance patient outcomes. Doxorubicin (DOX), a type of anthracyclin...

Full description

Saved in:
Bibliographic Details
Main Authors: Elyar Mahboubi, Mahdieh Mondanizadeh, Amir Almasi-Hashiani, Elham Ghasemi
Format: Article
Language:English
Published: BMC 2025-05-01
Series:European Journal of Medical Research
Subjects:
Online Access:https://doi.org/10.1186/s40001-025-02674-5
Tags: Add Tag
No Tags, Be the first to tag this record!